OpenCloses in 74 days
Source verified July 9, 2026
CLEAR Operating Grant
Support for high-impact dementia research
Latest source updateLast Update: July 9, 2026Latest change: The 2026 CLEAR Operating Grants are now open, with new dates, a new submission package and portal, updated contact email, and a tighter research focus on high-impact biomedical ADRD research.View change
Latest source update
Last Update: July 9, 2026
Latest change: The 2026 CLEAR Operating Grants are now open, with new dates, a new submission package and portal, updated contact email, and a tighter research focus on high-impact biomedical ADRD research.
CLEAR 2026 Operating Grants now open
The 2026 CLEAR Operating Grants are now open. The funding opportunity now states two 2026 Operating Grants supporting high-impact biomedical research on Alzheimer’s disease and related dementias (ADRD), with applications due September 25, 2026 at 11:59 PM PST, recipients announced in November 2026, and funding made available in December 2026. The submission process now points applicants to a 2026 Operating Grants Submission Package ZIP file and the Keela portal at https://signup-can.keela.co/2026-clear-operating-grant, and the contact email shown for questions is sheilascott@clearalzheimers.ca. The visible funding framing has shifted from the prior $400,000 over two years to a description of two 2026 Operating Grants, and the stated scope now emphasizes high-impact biomedical research with strong translational potential and meaningful therapeutic or clinical impact.
Funding available
Varies by project
Deadline
September 25, 2026
Opened June 25, 2026
Location
British Columbia, Canada
Overview
CLEAR Foundation’s 2026 Operating Grants support high-impact biomedical research focused on Alzheimer’s disease and related dementias (ADRD). The program aims to accelerate innovative projects with translational potential toward meaningful therapeutic or clinical impact, including disease mechanisms, new treatments, and early detection.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- British Columbia
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- Seniors
- Academia / students
Revenue structures
- 100% donations / grants
Scope
- Provincial
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Biomedical research on Alzheimer’s disease and related dementias (ADRD).
- Research that advances understanding of disease mechanisms.
- Research that supports the development of new treatments.
- Research that improves early detection.
- Research that accelerates discoveries with potential to improve patient outcomes.
Documents Needed
- Final Operating Grants Submission (merged PDF)
Official resources
Eligibility
Who is eligible?
- Principal Investigators at assistant professor level or higher
- Co-Principal Investigators at assistant professor level or higher
- Academic institutions in British Columbia
- Research teams working on dementia-related projects
Who is not eligible
- Past CLEAR Operating Grant recipients applying again as Principal Investigator within two calendar years after their funding term
Eligible expenses
- Direct research project costs
- Research activities covered by the approved budget
Ineligible Costs and Activities
- Indirect research costs
Eligible geographic areas
- British Columbia
Selection criteria
- CLEAR’s funding criteria.
- Scientific merit.
- Innovation.
- Feasibility.
- Potential impact.
How to apply
- Download the 2026 Operating Grants Submission Package.
- Prepare all forms and documentation for submission.
- Upload your submission via the online submission portal.
Processing and Agreement
- Submissions are reviewed by an independent committee of scientific experts, typically from outside British Columbia.
- Each proposal is assessed against CLEAR’s funding criteria, scientific merit, innovation, feasibility, and potential impact.
- The Review Committee meets to discuss each submission and finalize scores; all reviews and deliberations remain strictly confidential.
- Funding recommendations are provided to the Board of Directors, which approves grant expenditures based on the peer review results.
- In some cases, CLEAR partners with trusted research organizations that use their own established peer review processes, and the Board approves expenditures in accordance with agreed-upon partnership terms.
Additional information
- The application may be signed and transmitted using a digital/electronic signature.
- Applications must be submitted as one merged PDF document.
- Funding is typically provided annually during the grant term.
- All awardees must submit annual research progress reports.
Contacts
Frequently Asked Questions about the CLEAR Operating Grant Program
What is the CLEAR Operating Grant?
CLEAR Foundation’s 2026 Operating Grants support high-impact biomedical research focused on Alzheimer’s disease and related dementias (ADRD). The program aims to accelerate innovative projects with translational potential toward meaningful therapeutic or clinical impact, including disease mechanisms, new treatments, and early detection.
What is the deadline to apply?
The application deadline for this grant program is September 25, 2026. Applicants must submit their complete application before this date to be considered for funding.
Who is eligible for the CLEAR Operating Grant program?
To be eligible for the CLEAR Operating Grant program, you must:
Research on Alzheimer’s disease or related dementias.
Applicant based at a BC academic institution.
Project shows collaboration and impact potential.
What expenses are eligible under CLEAR Operating Grant?
Biomedical research on Alzheimer’s disease and related dementias (ADRD).
Research that advances understanding of disease mechanisms.
Research that supports the development of new treatments.
Research that improves early detection.
Research that accelerates discoveries with potential to improve patient outcomes.
Who can I contact for more information about the CLEAR Operating Grant?
You can contact CLEAR Foundation (CLEAR) by email at sheilascott@clearalzheimers.ca or by phone at none.
Where is the CLEAR Operating Grant available?
The CLEAR Operating Grant program is available the province of British Columbia.
Is the CLEAR Operating Grant a grant, loan, or tax credit?
CLEAR Operating Grant is a Grant and Funding